MedTrace Logo

A Feasibility Study for the One-dose Clinical Trial (1DT)

NCT02799732 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2016-06-15

No results posted yet for this study

Summary

This feasibility study was developed to evaluate the proposed approaches for enrollment, sample collection, interview and retention over a six-month vaccination period for the clinical trial: "A scientific evaluation of one and two doses of the bivalent and nonavalent prophylactic HPV vaccines" (1DT) currently under development . These aspects will be assessed quantitatively and qualitatively by measuring the efforts needed to identify and recruit each study participant, the participation rate for the study, and the retention rate at six months, as well as collecting information on the acceptability of study procedures. To supplement the assessment of the acceptability of the self-collected swab among older girls, a parallel effort will be done at the end of this feasibility study. Combined, this feasibility work will allow for modifications to the design, approaches and methods of the new trial.

Conditions

  • Compliance

Sponsors & Collaborators

  • Fundación Inciensa

    lead OTHER

Eligibility

Min Age
12 Years
Max Age
16 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2017-03-31
Completion
2017-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02799732 on ClinicalTrials.gov